Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Nerdy Inc. (NRDY) Reports Q2 Loss, Beats Revenue Estimates
Nerdy Inc. (NRDY) Reports Q2 Loss, Beats Revenue Estimates

Nerdy Inc. (NRDY) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.07 per share a year ago. These figures are adjusted for

Ouster, Inc. (OUST) Reports Q2 Loss, Beats Revenue Estimates
Ouster, Inc. (OUST) Reports Q2 Loss, Beats Revenue Estimates

Ouster, Inc. (OUST) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to a loss of $0.38 per share a year ago. These figures are

Octave Specialty Group (OSG) Reports Q2 Loss, Beats Revenue Estimates
Octave Specialty Group (OSG) Reports Q2 Loss, Beats Revenue Estimates

Octave Specialty Group (OSG) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.22 per share a year ago. These

Omada Health, Inc. (OMDA) Q2 Earnings and Revenues Top Estimates
Omada Health, Inc. (OMDA) Q2 Earnings and Revenues Top Estimates

Omada Health, Inc. (OMDA) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to a loss of $0.09 per share a year ago. These

Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue EstimatesPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates

Outset Medical, Inc. (OM) came out with a quarterly loss of $0.8 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to a loss of $0.84 per share a year ago. These

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates

Maravai LifeSciences Holdings, Inc. (MRVI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.08 per share a year

NerdWallet, Inc. (NRDS) Q2 Earnings Miss Estimates
NerdWallet, Inc. (NRDS) Q2 Earnings Miss Estimates

NerdWallet, Inc. (NRDS) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.11 per share a year ago. These

Northern Oil and Gas (NOG) Q2 Earnings and Revenues Surpass EstimatesPhoto, wide shot, wide-angle lens,  Coal company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.midjourneyapi.xyz/temp/2a011bdc-adca-4de9-8457-d868b31178cf.png
Northern Oil and Gas (NOG) Q2 Earnings and Revenues Surpass Estimates

Northern Oil and Gas (NOG) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $1.37 per share a year ago

Cloudflare (NET) Tops Q2 Earnings and Revenue Estimates
Cloudflare (NET) Tops Q2 Earnings and Revenue Estimates

Cloudflare (NET) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.21 per share a year ago. These figures

Monster Beverage (MNST) Surpasses Q2 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Brewery, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.theapi.app/temp/0cebecb6-c4f6-4c6e-b73e-f375daba8100.png
Monster Beverage (MNST) Surpasses Q2 Earnings and Revenue Estimates

Monster Beverage (MNST) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.52 per share a year ago. These

Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates
Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates

Lineage Cell (LCTX) came out with a quarterly loss of $0.03 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.01 per share a year ago. These figures are adjusted for

Innodata Inc (INOD) Surpasses Q2 Earnings and Revenue Estimates
Innodata Inc (INOD) Surpasses Q2 Earnings and Revenue Estimates

Innodata Inc (INOD) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.2 per share a year ago. These

ICF International (ICFI) Q2 Earnings Beat Estimates
ICF International (ICFI) Q2 Earnings Beat Estimates

ICF International (ICFI) came out with quarterly earnings of $1.86 per share, beating the Zacks Consensus Estimate of $1.69 per share. This compares to earnings of $1.66 per share a year ago. These

Hamilton Insurance (HG) Q2 Earnings and Revenues Top EstimatesPhoto, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
Hamilton Insurance (HG) Q2 Earnings and Revenues Top Estimates

Hamilton Insurance (HG) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $1.55 per share a year ago. These

CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates
CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.2 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.29 per share a year ago. These figures are adjusted

Gladstone Investment (GAIN) Q1 Earnings and Revenues Beat Estimates
Gladstone Investment (GAIN) Q1 Earnings and Revenues Beat Estimates

Gladstone Investment (GAIN) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.24 per share a year ago

Drilling Tools International Corp. (DTI) Reports Q2 Loss, Lags Revenue Estimates
Drilling Tools International Corp. (DTI) Reports Q2 Loss, Lags Revenue Estimates

Drilling Tools International Corp. (DTI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.02 per share a year

Denali Therapeutics Inc. (DNLI) Reports Q2 Loss, Tops Revenue Estimates
Denali Therapeutics Inc. (DNLI) Reports Q2 Loss, Tops Revenue Estimates

Denali Therapeutics Inc. (DNLI) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to a loss of $0.72 per share a year ago. These

Cytokinetics (CYTK) Reports Q2 Loss, Beats Revenue Estimates
Cytokinetics (CYTK) Reports Q2 Loss, Beats Revenue Estimates

Cytokinetics (CYTK) came out with a quarterly loss of $1.5 per share versus the Zacks Consensus Estimate of a loss of $1.63. This compares to a loss of $1.12 per share a year ago. These figures are

BioMarin Pharmaceutical (BMRN) Surpasses Q2 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
BioMarin Pharmaceutical (BMRN) Surpasses Q2 Earnings and Revenue Estimates

BioMarin Pharmaceutical (BMRN) came out with quarterly earnings of $1.2 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $1.44 per share a year ago